New Delhi, 2 Jan 2025: The Central Drugs Standard Control Organisation (CDSCO) has sought the industry to start submitting the applications for clinical trial site addition and change of principal investigator through online mode, as part of streamlining the regulatory submission......
View Details

Related News

• Draft notification for extension of Schedule M published for comments (04-01-2025)

---

• Illegal medical shop busted in Hyderabad (04-01-2025)

---

• Rajasthan: Registration of psychiatric hospitals, doctors will be mandatory (04-01-2025)

---

• TSMC serves notice to Rushcare Hospitals for its alleged association with quacks (04-01-2025)

---

• Pharma teachers faking profiles at multiple institutions, face being blacklisted (04-01-2025)

---

• DCA officials seize falsely manufactured Calcium tablets worth Rs 1.5 lakh (04-01-2025)

---

• Cancer drugs present strongest innovation pipeline in next 5 years: Report (04-01-2025)

---

• US FDA Releases Draft Guidance on Sampling and Testing of In-Process Materials and Drug Products (04-01-2025)

---

• DEA Releases 2024 Edition of Drugs of Abuse Resource Guide (04-01-2025)

---

• Bhubaneswar gets sub-zonal office of CDSCO (04-01-2025)

---